BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Z, Zhao SJ, Liu Y. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. Eur J Med Chem 2019;183:111700. [PMID: 31546197 DOI: 10.1016/j.ejmech.2019.111700] [Cited by in Crossref: 105] [Cited by in F6Publishing: 70] [Article Influence: 35.0] [Reference Citation Analysis]
Number Citing Articles
1 Kumar L, Lal K, Kumar A, Kumar A. Synthesis, antimicrobial evaluation and docking studies of oxazolone-1,2,3-triazole-amide hybrids. Res Chem Intermed 2021;47:5079-97. [DOI: 10.1007/s11164-021-04588-3] [Reference Citation Analysis]
2 Anterbedy J, Mokenapelli S, Thalari G. Facial synthesis of novel 3-(2-methylbenzofuran-3-yl)-5-((4-(phenoxymethyl)-1H-1,2,3-triazole-1-yl)methyl)-1,2,4-oxadiazole derivatives. Synthetic Communications 2021;51:1417-24. [DOI: 10.1080/00397911.2021.1884881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lessa RCS, Gomes ACCA. Perillyl alcohol and its synthetic derivatives: the rising of a novel class of selective and potent antitumoral compounds. Med Chem Res. [DOI: 10.1007/s00044-022-02870-6] [Reference Citation Analysis]
4 El Azab IH, Bakr RB, Elkanzi NAA. Facile One-Pot Multicomponent Synthesis of Pyrazolo-Thiazole Substituted Pyridines with Potential Anti-Proliferative Activity: Synthesis, In Vitro and In Silico Studies. Molecules 2021;26:3103. [PMID: 34067399 DOI: 10.3390/molecules26113103] [Reference Citation Analysis]
5 Abdel-rady M, Mahross MH, El-adasy AA, Atalla AA, Khames AA, Hussein AHM. Functionally substituted arylhydrazones as building blocks in heterocyclic synthesis: Facile synthesis of pyrazoles, triazoles, triazines and quantum chemical studies. Synthetic Communications 2021;51:3099-115. [DOI: 10.1080/00397911.2021.1961275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Narsimha S, Nukala SK, Savitha Jyostna T, Ravinder M, Srinivasa Rao M, Vasudeva Reddy N. One‐pot synthesis and biological evaluation of novel 4‐[3‐fluoro‐4‐(morpholin‐4‐yl)]phenyl‐1 H ‐1,2,3‐triazole derivatives as potent antibacterial and anticancer agents. J Heterocycl Chem 2020;57:1655-65. [DOI: 10.1002/jhet.3890] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
7 Ding Z, Zhou M, Zeng C. Recent advances in isatin hybrids as potential anticancer agents. Arch Pharm (Weinheim) 2020;353:e1900367. [PMID: 31960987 DOI: 10.1002/ardp.201900367] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
8 Maračić S, Grbčić P, Shammugam S, Radić Stojković M, Pavelić K, Sedić M, Kraljević Pavelić S, Raić-Malić S. Amidine- and Amidoxime-Substituted Heterocycles: Synthesis, Antiproliferative Evaluations and DNA Binding. Molecules 2021;26:7060. [PMID: 34834151 DOI: 10.3390/molecules26227060] [Reference Citation Analysis]
9 Seghetti F, Di Martino RMC, Catanzaro E, Bisi A, Gobbi S, Rampa A, Canonico B, Montanari M, Krysko DV, Papa S, Fimognari C, Belluti F. Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery. Molecules 2020;25:E3066. [PMID: 32635622 DOI: 10.3390/molecules25133066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Druzina AA, Zhidkova OB, Dudarova NV, Kosenko ID, Ananyev IV, Timofeev SV, Bregadze VI. Synthesis and Structure of Nido-Carboranyl Azide and Its "Click" Reactions. Molecules 2021;26:530. [PMID: 33498488 DOI: 10.3390/molecules26030530] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nural Y, Ozdemir S, Yalcin MS, Demir B, Atabey H, Seferoglu Z, Ece A. New bis- and tetrakis-1,2,3-triazole derivatives: Synthesis, DNA cleavage, molecular docking, antimicrobial, antioxidant activity and acid dissociation constants. Bioorg Med Chem Lett 2022;55:128453. [PMID: 34801684 DOI: 10.1016/j.bmcl.2021.128453] [Reference Citation Analysis]
12 Poonia N, Lal K, Kumar A, Kumar A, Sahu S, Baidya ATK, Kumar R. Urea-thiazole/benzothiazole hybrids with a triazole linker: synthesis, antimicrobial potential, pharmacokinetic profile and in silico mechanistic studies. Mol Divers 2021. [PMID: 34671895 DOI: 10.1007/s11030-021-10336-x] [Reference Citation Analysis]
13 Reddy NN, Hung SJ, Swamy MK, Sanjeev A, Rao VS, Rohini R, Raju AK, Bhaskar K, Hu A, Reddy PM. Synthesis and Rational Design of New Appended 1,2,3-Triazole-uracil Ensembles as Promising Anti-Tumor Agents via In Silico VEGFR-2 Transferase Inhibition. Molecules 2021;26:1952. [PMID: 33808444 DOI: 10.3390/molecules26071952] [Reference Citation Analysis]
14 Navacchia ML, Marchesi E, Perrone D. Bile Acid Conjugates with Anticancer Activity: Most Recent Research. Molecules 2020;26:E25. [PMID: 33374573 DOI: 10.3390/molecules26010025] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Feng LS, Zheng MJ, Zhao F, Liu D. 1,2,3-Triazole hybrids with anti-HIV-1 activity. Arch Pharm (Weinheim) 2021;354:e2000163. [PMID: 32960467 DOI: 10.1002/ardp.202000163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
16 Kasemsuk T, Saehlim N, Arsakhant P, Sittithumcharee G, Okada S, Saeeng R. A novel synthetic acanthoic acid analogues and their cytotoxic activity in cholangiocarcinoma cells. Bioorg Med Chem 2021;29:115886. [PMID: 33290909 DOI: 10.1016/j.bmc.2020.115886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Efremova MM, Govdi AI, Frolova VV, Rumyantsev AM, Balova IA. Design and Synthesis of New 5-aryl-4-Arylethynyl-1H-1,2,3-triazoles with Valuable Photophysical and Biological Properties. Molecules 2021;26:2801. [PMID: 34068559 DOI: 10.3390/molecules26092801] [Reference Citation Analysis]
18 Sokolnikova TV, Proidakov AG, Kizhnyaev VN. Organocatalytic Enamine–Azide Addition Reaction in the Synthesis of 1,4,5-Trisubstituted 1,2,3-Triazoles. Russ J Org Chem 2021;57:376-82. [DOI: 10.1134/s1070428021030088] [Reference Citation Analysis]
19 Kerru N, Gummidi L, Maddila S, Gangu KK, Jonnalagadda SB. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules 2020;25:E1909. [PMID: 32326131 DOI: 10.3390/molecules25081909] [Cited by in Crossref: 92] [Cited by in F6Publishing: 37] [Article Influence: 46.0] [Reference Citation Analysis]
20 Pereira D, Pinto M, Correia-da-Silva M, Cidade H. Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry. Molecules 2021;27:230. [PMID: 35011463 DOI: 10.3390/molecules27010230] [Reference Citation Analysis]
21 El Azab IH, Saied EM, Osman AA, Mehana AE, Saad HA, Elkanzi NA. Novel N-bridged pyrazole-1-carbothioamides with potential antiproliferative activity: design, synthesis, in vitro and in silico studies. Future Med Chem 2021;13:1743-66. [PMID: 34427113 DOI: 10.4155/fmc-2021-0066] [Reference Citation Analysis]
22 Rashdan HRM, Shehadi IA, Abdelmonsef AH. Synthesis, Anticancer Evaluation, Computer-Aided Docking Studies, and ADMET Prediction of 1,2,3-Triazolyl-Pyridine Hybrids as Human Aurora B Kinase Inhibitors. ACS Omega 2021;6:1445-55. [PMID: 33490804 DOI: 10.1021/acsomega.0c05116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
23 Gao F, Sun Z, Kong F, Xiao J. Artemisinin-derived hybrids and their anticancer activity. Eur J Med Chem 2020;188:112044. [PMID: 31945642 DOI: 10.1016/j.ejmech.2020.112044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
24 Lal K, Poonia N, Rani P, Kumar A, Kumar A. Design, synthesis, antimicrobial evaluation and docking studies of urea-triazole-amide hybrids. Journal of Molecular Structure 2020;1215:128234. [DOI: 10.1016/j.molstruc.2020.128234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
25 Agrahari AK, Bose P, Jaiswal MK, Rajkhowa S, Singh AS, Hotha S, Mishra N, Tiwari VK. Cu(I)-Catalyzed Click Chemistry in Glycoscience and Their Diverse Applications. Chem Rev 2021;121:7638-956. [PMID: 34165284 DOI: 10.1021/acs.chemrev.0c00920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Al Sheikh Ali A, Khan D, Naqvi A, Al-Blewi FF, Rezki N, Aouad MR, Hagar M. Design, Synthesis, Molecular Modeling, Anticancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives. ACS Omega 2021;6:301-16. [PMID: 33458482 DOI: 10.1021/acsomega.0c04595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
27 Ye J, Mao L, Xie L, Zhang R, Liu Y, Peng L, Yang J, Li Q, Yuan M. Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer. Front Pharmacol 2021;12:753676. [PMID: 34764872 DOI: 10.3389/fphar.2021.753676] [Reference Citation Analysis]
28 Jagadale SM, Abhale YK, Pawar HR, Shinde A, Bobade VD, Chavan AP, Sarkar D, Mhaske PC. Synthesis of New Thiazole and Pyrazole Clubbed 1,2,3-Triazol Derivatives as Potential Antimycobacterial and Antibacterial Agents. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2020.1857272] [Reference Citation Analysis]
29 Shalini, Kumar V. Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on? Expert Opin Drug Discov 2021;16:335-63. [PMID: 33305635 DOI: 10.1080/17460441.2021.1850686] [Reference Citation Analysis]
30 Pinheiro S, Pessôa JC, Pinheiro EMC, Muri EMF, Filho EV, Loureiro LB, Freitas MCR, Silva Junior CMD, Fiorot RG, Carneiro JWM, Rotamiro KM, Guimarães ARA, Rocha-Brito KJP, Greco SJ. 2H-1,2,3-Triazole-chalcones as novel cytotoxic agents against prostate cancer. Bioorg Med Chem Lett 2020;30:127454. [PMID: 32736078 DOI: 10.1016/j.bmcl.2020.127454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Sooknual P, Pingaew R, Phopin K, Ruankham W, Prachayasittikul S, Ruchirawat S, Prachayasittikul V. Synthesis and neuroprotective effects of novel chalcone-triazole hybrids. Bioorganic Chemistry 2020;105:104384. [DOI: 10.1016/j.bioorg.2020.104384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Kumari GS, Siva B, Reddy SD, Nayak VL, Tiwari AK, Rao BG, Babu KS. Synthesis and biological evaluation of 1,2,3-triazole hybrids of 4-methoxy ethyl cinnamate isolated from Hedychium spicatum (Sm) rhizomes: identification of antiproliferative lead actives against prostate cancer. Nat Prod Res 2021;:1-7. [PMID: 34579616 DOI: 10.1080/14786419.2021.1969928] [Reference Citation Analysis]
33 Sai Allaka B, Basavoju S, Rama Krishna G. A Photoinduced Multicomponent Regioselective Synthesis of 1,4,5‐Trisubstituted‐1,2,3‐Triazoles: Transition Metal‐, Azide‐ and Oxidant‐Free Protocol. Adv Synth Catal 2021;363:3560-5. [DOI: 10.1002/adsc.202100321] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Su Q, Xu B, Tian Z, Gong Z. Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway. Acta Pharmaceutica 2022;72:389-402. [DOI: 10.2478/acph-2022-0026] [Reference Citation Analysis]
35 Matiadis D, Sagnou M. Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview. Int J Mol Sci 2020;21:E5507. [PMID: 32752126 DOI: 10.3390/ijms21155507] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
36 Zhang X, Jia Y. Recent Advances in β-lactam Derivatives as Potential Anticancer Agents. Curr Top Med Chem 2020;20:1468-80. [PMID: 32148196 DOI: 10.2174/1568026620666200309161444] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Khwaza V, Mlala S, Oyedeji OO, Aderibigbe BA. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery. Molecules 2021;26:2401. [PMID: 33918996 DOI: 10.3390/molecules26092401] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
38 Melge AR, Parate S, Pavithran K, Koyakutty M, Mohan CG. Discovery of Anticancer Hybrid Molecules by Supervised Machine Learning Models and in Vitro Validation in Drug Resistant Chronic Myeloid Leukemia Cells. J Chem Inf Model 2022. [PMID: 35172577 DOI: 10.1021/acs.jcim.1c01554] [Reference Citation Analysis]
39 Patrushev SS, Rybalova TV, Shults EE. Synthetic transformations of sesquiterpene lactones. Controllable synthesis of 11,13-dihydroisoalantolactone azides and 13-(1,2,3-triazolyl)eudesmanolides based on sesquiterpene lactones. Chem Heterocycl Comp 2021;57:1116-29. [DOI: 10.1007/s10593-021-03030-1] [Reference Citation Analysis]
40 Zhang X, Basuli F, Abdelwahed S, Begley T, Swenson R. Radiosynthesis of 5-[18F]Fluoro-1,2,3-triazoles through Aqueous Iodine-[18F]Fluorine Exchange Reaction. Molecules 2021;26:5522. [PMID: 34576993 DOI: 10.3390/molecules26185522] [Reference Citation Analysis]
41 Kadela-Tomanek M, Jastrzębska M, Marciniec K, Chrobak E, Bębenek E, Latocha M, Kuśmierz D, Boryczka S. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate. Bioorg Chem 2021;106:104478. [PMID: 33272711 DOI: 10.1016/j.bioorg.2020.104478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Badavath VN, Kumar A, Samanta PK, Maji S, Das A, Blum G, Jha A, Sen A. Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (mpro): a molecular docking, molecular dynamics and structure-activity relationship studies. J Biomol Struct Dyn 2020;:1-19. [PMID: 33200681 DOI: 10.1080/07391102.2020.1845800] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
43 Surendra Reddy G, Anebouselvy K, Ramachary DB. [3+2]‐Cycloaddition for Fully Decorated Vinyl‐1,2,3‐Triazoles: Design, Synthesis and Applications. Chem Asian J 2020;15:2960-83. [DOI: 10.1002/asia.202000731] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
44 Liu W, Liang Y, Si X. Hydroxamic acid hybrids as the potential anticancer agents: An Overview. European Journal of Medicinal Chemistry 2020;205:112679. [DOI: 10.1016/j.ejmech.2020.112679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
45 Nayak S, Gaonkar SL, Musad EA, Dawsar AMA. 1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships. Journal of Saudi Chemical Society 2021;25:101284. [DOI: 10.1016/j.jscs.2021.101284] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Caciolla J, Picone G, Farruggia G, Valenti D, Rampa A, Malucelli E, Belluti F, Trezza A, Spiga O, Iotti S, Gobbi S, Cappadone C, Bisi A. Multifaceted activity of polyciclic MDR revertant agents in drug-resistant leukemic cells: Role of the spacer. Bioorg Chem 2021;106:104460. [PMID: 33229118 DOI: 10.1016/j.bioorg.2020.104460] [Reference Citation Analysis]
47 Chaidam S, Saehlim N, Athipornchai A, Sirion U, Saeeng R. Synthesis and biological evaluation of 1,6-bis-triazole-2,3,4-tri-O-benzyl-α-d-glucopyranosides as a novel α-glucosidase inhibitor in the treatment of Type 2 diabetes. Bioorg Med Chem Lett 2021;50:128331. [PMID: 34418573 DOI: 10.1016/j.bmcl.2021.128331] [Reference Citation Analysis]
48 Mao L, Sun G, Zhao J, Xu G, Yuan M, Li YM. Design, synthesis and antitumor activity of icotinib derivatives. Bioorg Chem 2020;105:104421. [PMID: 33181408 DOI: 10.1016/j.bioorg.2020.104421] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 El Azab IH, El-Sheshtawy HS, Bakr RB, Elkanzi NAA. New 1,2,3-Triazole-Containing Hybrids as Antitumor Candidates: Design, Click Reaction Synthesis, DFT Calculations, and Molecular Docking Study. Molecules 2021;26:708. [PMID: 33573040 DOI: 10.3390/molecules26030708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020). Eur J Med Chem 2020;208:112830. [PMID: 32992133 DOI: 10.1016/j.ejmech.2020.112830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
51 Xu Z. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). Eur J Med Chem 2020;206:112686. [PMID: 32795773 DOI: 10.1016/j.ejmech.2020.112686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
52 Rezki N, Almehmadi MA, Ihmaid S, Shehata AM, Omar AM, Ahmed HEA, Aouad MR. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses. Bioorg Chem 2020;103:104133. [PMID: 32745759 DOI: 10.1016/j.bioorg.2020.104133] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
53 Şahin İ, Çeşme M, Yüce N, Tümer F. Discovery of new 1,4-disubstituted 1,2,3-triazoles: in silico ADME profiling, molecular docking and biological evaluation studies. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2025905] [Reference Citation Analysis]
54 Liu X, Pang XJ, Liu Y, Liu WB, Li YR, Yu GX, Zhang YB, Song J, Zhang SY. Discovery of Novel Diarylamide N-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity. Molecules 2021;26:4047. [PMID: 34279387 DOI: 10.3390/molecules26134047] [Reference Citation Analysis]
55 Wan Y, Fang G, Chen H, Deng X, Tang Z. Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation. Eur J Med Chem 2021;226:113837. [PMID: 34530384 DOI: 10.1016/j.ejmech.2021.113837] [Reference Citation Analysis]
56 Li YQ, Zheng Z, Liu QX, Lu X, Zhou D, Zhang J, Zheng H, Dai JG. Repositioning of Antiparasitic Drugs for Tumor Treatment. Front Oncol 2021;11:670804. [PMID: 33996598 DOI: 10.3389/fonc.2021.670804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Sapijanskaitė-Banevič B, Palskys V, Vaickelionienė R, Šiugždaitė J, Kavaliauskas P, Grybaitė B, Mickevičius V. Synthesis and Antibacterial Activity of New Azole, Diazole and Triazole Derivatives Based on p-Aminobenzoic Acid. Molecules 2021;26:2597. [PMID: 33946936 DOI: 10.3390/molecules26092597] [Reference Citation Analysis]
58 Akolkar SV, Nagargoje AA, Shaikh MH, Warshagha MZA, Sangshetti JN, Damale MG, Shingate BB. New N-phenylacetamide-linked 1,2,3-triazole-tethered coumarin conjugates: Synthesis, bioevaluation, and molecular docking study. Arch Pharm (Weinheim) 2020;353:e2000164. [PMID: 32776355 DOI: 10.1002/ardp.202000164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
59 Awolade P, Cele N, Kerru N, Singh P. Synthesis, antimicrobial evaluation, and in silico studies of quinoline-1H-1,2,3-triazole molecular hybrids. Mol Divers 2021;25:2201-18. [PMID: 32507981 DOI: 10.1007/s11030-020-10112-3] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Vicentes DE, Romero AL, Rodríguez R, Cobo J, Glidewell C. Conversion of 3-amino-4-arylamino-1H-isochromen-1-ones to 1-arylisochromeno[3,4-d][1,2,3]triazol-5(1H)-ones: synthesis, spectroscopic characterization and the structures of four products and one ring-opened derivative. Acta Crystallogr C Struct Chem 2020;76:446-53. [PMID: 32367825 DOI: 10.1107/S2053229620003757] [Reference Citation Analysis]
61 Afshar N, Hatamjafari F, Shiroudi A, Pourshamsian K, Oliaey AR. Synthesis and Characterization of Some New Indoline-Based 1,2,4-Triazole Derivatives. Russ J Org Chem 2020;56:2153-8. [DOI: 10.1134/s1070428020120179] [Reference Citation Analysis]
62 Pitucha M, Janeczko M, Klimek K, Fornal E, Wos M, Pachuta-stec A, Ginalska G, Kaczor AA. 1,2,4-Triazolin-5-thione derivatives with anticancer activity as CK1γ kinase inhibitors. Bioorganic Chemistry 2020;99:103806. [DOI: 10.1016/j.bioorg.2020.103806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Steppeler F, Kłopotowska D, Wietrzyk J, Wojaczyńska E. Synthesis and Antiproliferative Activity of Triazoles Based on 2-Azabicycloalkanes. Materials (Basel) 2021;14:2039. [PMID: 33919613 DOI: 10.3390/ma14082039] [Reference Citation Analysis]
64 Liang T, Sun X, Li W, Hou G, Gao F. 1,2,3-Triazole-Containing Compounds as Anti-Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure-Activity Relationship. Front Pharmacol 2021;12:661173. [PMID: 34177578 DOI: 10.3389/fphar.2021.661173] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Alraqa SY, Alharbi K, Aljuhani A, Rezki N, Aouad MR, Ali I. Design, click conventional and microwave syntheses, DNA binding, docking and anticancer studies of benzotriazole-1,2,3-triazole molecular hybrids with different pharmacophores. Journal of Molecular Structure 2021;1225:129192. [DOI: 10.1016/j.molstruc.2020.129192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
66 Saroha B, Kumar G, Kumar R, Kumari M, Kumar S. A minireview of 1,2,3-triazole hybrids with O-heterocycles as leads in medicinal chemistry. Chem Biol Drug Des 2021. [PMID: 34592059 DOI: 10.1111/cbdd.13966] [Reference Citation Analysis]
67 Hamdy R, Jones AT, El-Sadek M, Hamoda AM, Shakartalla SB, Al Shareef ZM, Soliman SSM, Westwell AD. New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents. Int J Mol Sci 2021;22:12272. [PMID: 34830153 DOI: 10.3390/ijms222212272] [Reference Citation Analysis]
68 Suryapeta S, Papigani N, Banothu V, Dubey PK, Mukkanti K, Pal S. Synthesis, biological evaluation, and docking study of a series of 1,4‐disubstituted 1,2,3‐triazole derivatives with an indole‐triazole‐peptide conjugate. J Heterocyclic Chem 2020;57:3126-41. [DOI: 10.1002/jhet.4020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
69 Talukdar R, Singh V, Mourya H, Nasibullah M, Tiwari B. Stitching Triazoles to Arenes via a Transition Metal-Free Aryne Diels-Alder/1,3-Prototropic Shift/Dehydrobromination Cascade. J Org Chem 2021;86:12277-84. [PMID: 34328329 DOI: 10.1021/acs.joc.1c00562] [Reference Citation Analysis]
70 Yan X, Wen J, Zhou L, Fan L, Wang X, Xu Z. Current Scenario of 1,3-oxazole Derivatives for Anticancer Activity. CTMC 2020;20:1916-37. [DOI: 10.2174/1568026620666200624161151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
71 Pourabdi L, Küçükkılınç TT, Khoshtale F, Ayazgök B, Nadri H, Farokhi Alashti F, Forootanfar H, Akbari T, Shafiei M, Foroumadi A, Sharifzadeh M, Shafiee Ardestani M, Abaee MS, Firoozpour L, Khoobi M, Mojtahedi MM. Synthesis of New 3-Arylcoumarins Bearing N-Benzyl Triazole Moiety: Dual Lipoxygenase and Butyrylcholinesterase Inhibitors With Anti-Amyloid Aggregation and Neuroprotective Properties Against Alzheimer’s Disease. Front Chem 2022;9:810233. [DOI: 10.3389/fchem.2021.810233] [Reference Citation Analysis]
72 Bębenek E, Kadela-tomanek M, Chrobak E, Jastrzębska M, Książek M. Synthesis and Structural Characterization of a New 1,2,3-Triazole Derivative of Pentacyclic Triterpene. Crystals 2022;12:422. [DOI: 10.3390/cryst12030422] [Reference Citation Analysis]
73 Murthy AVR, Narendar V, Sampath Kumar N, Aparna P, Bhavani AKD, Solhi H, Le Guevel R, Roul J, Gautier F, Juin P, Reddy CR, Mosset P, Levoin N, Grée R. Synthesis and biological studies of new piperidino-1,2,3-triazole hybrids with 3-aryl isoxazole side chains. Bioorg Med Chem Lett 2021;52:128390. [PMID: 34601029 DOI: 10.1016/j.bmcl.2021.128390] [Reference Citation Analysis]
74 Gondru R, Kanugala S, Raj S, Ganesh Kumar C, Pasupuleti M, Banothu J, Bavantula R. 1,2,3-triazole-thiazole hybrids: Synthesis, in vitro antimicrobial activity and antibiofilm studies. Bioorganic & Medicinal Chemistry Letters 2021;33:127746. [DOI: 10.1016/j.bmcl.2020.127746] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
75 Kella CR, Balachandran C, Arun Y, Kaliyappan E, Mahalingam SM, Ignacimuthu S, Arumugam N, Almansour AI, Suresh Kumar R, Perumal PT. A novel class of 1,4-disubstituted 1,2,3-triazoles: Regioselective synthesis, antimicrobial activity and molecular docking studies. Arabian Journal of Chemistry 2020;13:9047-57. [DOI: 10.1016/j.arabjc.2020.10.026] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Yang W, Xuan B, Li X, Si H, Chen A. Therapeutic potential of 1,2,3-triazole hybrids for leukemia treatment. Arch Pharm (Weinheim) 2022;:e2200106. [PMID: 35532286 DOI: 10.1002/ardp.202200106] [Reference Citation Analysis]
77 Glanzmann N, Antinarelli LMR, da Costa Nunes IK, Pereira HMG, Coelho EAF, Coimbra ES, da Silva AD. Synthesis and biological activity of novel 4-aminoquinoline/1,2,3-triazole hybrids against Leishmania amazonensis. Biomed Pharmacother 2021;141:111857. [PMID: 34323702 DOI: 10.1016/j.biopha.2021.111857] [Reference Citation Analysis]
78 Danilkina NA, D'yachenko AS, Govdi AI, Khlebnikov AF, Kornyakov IV, Bräse S, Balova IA. Intramolecular Nicholas Reactions in the Synthesis of Heteroenediynes Fused to Indole, Triazole, and Isocoumarin. J Org Chem 2020;85:9001-14. [PMID: 32506914 DOI: 10.1021/acs.joc.0c00930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
79 Ostlund T, Alotaibi F, Kyeremateng J, Halaweish H, Kasten A, Iram S, Halaweish F. Triazole-estradiol analogs: A potential cancer therapeutic targeting ovarian and colorectal cancer. Steroids 2022;177:108950. [PMID: 34933058 DOI: 10.1016/j.steroids.2021.108950] [Reference Citation Analysis]
80 Aguilar-Morales CM, Araujo-Huitrado JG, López-Hernández Y, Contreras-Celedón C, Islas-Jácome A, Granados-López AJ, Solorio-Alvarado CR, López JA, Chacón-García L, Cortés-García CJ. A One-Pot Six-Component Reaction for the Synthesis of 1,5-Disubstituted Tetrazol-1,2,3-Triazole Hybrids and Their Cytotoxic Activity against the MCF-7 Cell Line. Molecules 2021;26:6104. [PMID: 34684686 DOI: 10.3390/molecules26206104] [Reference Citation Analysis]
81 Prakash L. Kalavadiya, Kapupara VH, Gojiya DG, Bhatt TD, Hadiyal SD, Joshi DHS. Ultrasonic-Assisted Synthesis of Pyrazolo[3,4-d]pyrimidin-4-ol Tethered with 1,2,3-Triazoles and Their Anticancer Activity. Russ J Bioorg Chem 2020;46:803-13. [DOI: 10.1134/s1068162020050106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
82 Padhariya KN, Athavale M, Srivastava S, Kharkar PS. A novel series of substituted 1,2,3-triazoles as cancer stem cell inhibitors: Synthesis and biological evaluation. Drug Dev Res 2021;82:68-85. [PMID: 32783257 DOI: 10.1002/ddr.21723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Tan Z, Deng J, Ye Q, Zhang Z. Triazole-containing hybrids with anti-Mycobacterium tuberculosis potential - Part I: 1,2,3-Triazole. Future Med Chem 2021;13:643-62. [PMID: 33619989 DOI: 10.4155/fmc-2020-0301] [Reference Citation Analysis]
84 Hou Y, Shang C, Meng T, Lou W. Anticancer potential of cardiac glycosides and steroid-azole hybrids. Steroids 2021;171:108852. [PMID: 33887267 DOI: 10.1016/j.steroids.2021.108852] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
85 Nural Y, Ozdemir S, Doluca O, Demir B, Yalcin MS, Atabey H, Kanat B, Erat S, Sari H, Seferoglu Z. Synthesis, biological properties, and acid dissociation constant of novel naphthoquinone–triazole hybrids. Bioorganic Chemistry 2020;105:104441. [DOI: 10.1016/j.bioorg.2020.104441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
86 Veligeti R, Madhu RB, Anireddy J, Pasupuleti VR, Avula VKR, Ethiraj KS, Uppalanchi S, Kasturi S, Perumal Y, Anantaraju HS, Polkam N, Guda MR, Vallela S, Zyryanov GV. Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties. Sci Rep 2020;10:20720. [PMID: 33244007 DOI: 10.1038/s41598-020-77590-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Tratrat C, Haroun M, Paparisva A, Kamoutsis C, Petrou A, Gavalas A, Eleftheriou P, Geronikaki A, Venugopala KN, Kochkar H, Nair AB. New Substituted 5-Benzylideno-2-Adamantylthiazol[3,2-b][1,2,4]Triazol-6(5H)ones as Possible Anti-Inflammatory Agents. Molecules 2021;26:659. [PMID: 33513963 DOI: 10.3390/molecules26030659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Wen X, Zhou Y, Zeng J, Liu X. Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents. CTMC 2020;20:1441-60. [DOI: 10.2174/1568026620666200128143230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
89 Zhang X, Zhang S, Zhao S, Wang X, Liu B, Xu H. Click Chemistry in Natural Product Modification. Front Chem 2021;9:774977. [PMID: 34869223 DOI: 10.3389/fchem.2021.774977] [Reference Citation Analysis]
90 Fan Y, Huang Z, Wang X, Ma Y, Li Y, Yang S, Shi Y. Discovery of 12O-A Novel Oral Multi-Kinase Inhibitor for the Treatment of Solid Tumor. Molecules 2020;25:E5199. [PMID: 33182255 DOI: 10.3390/molecules25215199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Poonia N, Lal K, Kumar A. 1,3-Phenylene-based symmetrical bis(urea-1,2,3-triazole) hybrids: Synthesis, antimicrobial and in silico studies as 14α-sterol demethylase inhibitors. Res Chem Intermed. [DOI: 10.1007/s11164-021-04653-x] [Reference Citation Analysis]
92 Wang DP, Liu KL, Li XY, Lu GQ, Xue WH, Qian XH, Mohamed O K, Meng FH. Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold. Eur J Med Chem 2021;211:113083. [PMID: 33340911 DOI: 10.1016/j.ejmech.2020.113083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Ihmaid SK, Alraqa SY, Aouad MR, Aljuhani A, Elbadawy HM, Salama SA, Rezki N, Ahmed HEA. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability. Bioorg Chem 2021;111:104835. [PMID: 33798850 DOI: 10.1016/j.bioorg.2021.104835] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Anand A, Sindogi K, Dixit SR, Shetty RP, Pujar GV, Kulkarni MV, Guru Row TN. Comparative Investigation on the Crystal Structures, Hirshfeld Surface Analysis, Antitubercular Assays, and Molecular Docking of Regioisomeric 1,2,3‐Triazoles. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202104352] [Reference Citation Analysis]
95 Smyshliaeva LA, Varaksin MV, Fomina EI, Joy MN, Bakulev VA, Charushin VN, Chupakhin ON. Cu(I)-Catalyzed Cycloaddition of Vinylacetylene ortho -Carborane and Arylazides in the Design of 1,2,3-Triazolyl-Modified Vinylcarborane Fluorophores. Organometallics 2020;39:3679-88. [DOI: 10.1021/acs.organomet.0c00478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
96 Gao W, Hu H, Dai L, He M, Yuan H, Zhang H, Liao J, Wen B, Li Y, Palmisano M, Traore MDM, Zhou S, Sun D. Structure‒tissue exposure/selectivity relationship (STR) correlates with clinical efficacy/safety. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.015] [Reference Citation Analysis]
97 Aissa I, Abdelkafi-Koubaa Z, Chouaïb K, Jalouli M, Assel A, Romdhane A, Harrath AH, Marrakchi N, Ben Jannet H. Glioblastoma-specific anticancer activity of newly synthetized 3,5-disubstituted isoxazole and 1,4-disubstituted triazole-linked tyrosol conjugates. Bioorg Chem 2021;114:105071. [PMID: 34130108 DOI: 10.1016/j.bioorg.2021.105071] [Reference Citation Analysis]
98 Majeed K, Wang L, Liu B, Guo Z, Zhou F, Zhang Q. Metal-Free Tandem Approach for Triazole-Fused Diazepinone Scaffolds via [3 + 2]Cycloaddition/C–N Coupling Reaction. J Org Chem 2021;86:207-22. [DOI: 10.1021/acs.joc.0c02022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
99 Aly AA, A Hassan A, Makhlouf MM, Bräse S. Chemistry and Biological Activities of 1,2,4-Triazolethiones-Antiviral and Anti-Infective Drugs. Molecules 2020;25:E3036. [PMID: 32635156 DOI: 10.3390/molecules25133036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
100 Li S, Li X, Zhang T, Zhu J, Xue W, Qian X, Meng F. Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors. Bioorganic Chemistry 2020;96:103575. [DOI: 10.1016/j.bioorg.2020.103575] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
101 Mohammed HHH, Abd El-Hafeez AA, Ebeid K, Mekkawy AI, Abourehab MAS, Wafa EI, Alhaj-Suliman SO, Salem AK, Ghosh P, Abuo-Rahma GEA, Hayallah AM, Abbas SH. New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization. J Enzyme Inhib Med Chem 2022;37:1346-63. [PMID: 35548854 DOI: 10.1080/14756366.2022.2072308] [Reference Citation Analysis]
102 Krzywik J, Nasulewicz-Goldeman A, Mozga W, Wietrzyk J, Huczyński A. Novel Double-Modified Colchicine Derivatives Bearing 1,2,3-Triazole: Design, Synthesis, and Biological Activity Evaluation. ACS Omega 2021;6:26583-600. [PMID: 34661013 DOI: 10.1021/acsomega.1c03948] [Reference Citation Analysis]
103 Vagish CB, Kumara K, Vivek HK, Bharath S, Lokanath NK, Ajay Kumar K. Coumarin-triazole hybrids: Design, microwave-assisted synthesis, crystal and molecular structure, theoretical and computational studies and screening for their anticancer potentials against PC-3 and DU-145. Journal of Molecular Structure 2021;1230:129899. [DOI: 10.1016/j.molstruc.2021.129899] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
104 Fall SAK, Hajib S, Karai O, Boukhssas S, Aouine Y, Akhazzane M, Labriti B, Faraj H, Alami A. Naphthalen-2-yl 1-(benzamido(diethoxyphosphoryl)methyl)-1H-1,2,3-triazole-4-carboxylate. Molbank 2021;2021:M1285. [DOI: 10.3390/m1285] [Reference Citation Analysis]
105 Arshad M, Khan MS, Nami SAA. Norfloxacin Analogues: Drug Likeness, Synthesis, Biological, and Molecular Docking Assessment. Russ J Bioorg Chem 2021;47:483-95. [DOI: 10.1134/s1068162021020047] [Reference Citation Analysis]
106 Akhtar W, Marella A, Alam MM, Khan MF, Akhtar M, Anwer T, Khan F, Naematullah M, Azam F, Rizvi MA, Shaquiquzzaman M. Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitors. Arch Pharm (Weinheim) 2021;354:e2000116. [PMID: 33015829 DOI: 10.1002/ardp.202000116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Shahzadi I, Zahoor AF, Rasul A, Mansha A, Ahmad S, Raza Z. Synthesis, Hemolytic Studies, and In Silico Modeling of Novel Acefylline-1,2,4-Triazole Hybrids as Potential Anti-cancer Agents against MCF-7 and A549. ACS Omega 2021;6:11943-53. [PMID: 34056349 DOI: 10.1021/acsomega.1c00424] [Reference Citation Analysis]
108 Mohamed Abdelahi MM, El Bakri Y, Lai CH, Subramani K, Anouar EH, Ahmad S, Benchidmi M, Mague JT, Popović-Djordjević J, Goumri-Said S. Novel 3-chloro-6-nitro-1H-indazole derivatives as promising antileishmanial candidates: synthesis, biological activity, and molecular modelling studies. J Enzyme Inhib Med Chem 2022;37:151-67. [PMID: 34894940 DOI: 10.1080/14756366.2021.1995380] [Reference Citation Analysis]
109 Theeramunkong S, Maicheen C, Krongsil R, Chaichanasap W, Asasutjarit R, Vajragupta O. Synthesis and in vitro biological evaluation of (iso)quinoline-1,2,3-triazole derivatives as anticancer agents. Chem Pap . [DOI: 10.1007/s11696-022-02140-0] [Reference Citation Analysis]
110 Hernández-López H, Leyva-Ramos S, Azael Gómez-Durán CF, Pedraza-Alvarez A, Rodríguez-Gutiérrez IR, Leyva-Peralta MA, Razo-Hernández RS. Synthesis of 1,4-Biphenyl-triazole Derivatives as Possible 17β-HSD1 Inhibitors: An in Silico Study. ACS Omega 2020;5:14061-8. [PMID: 32566872 DOI: 10.1021/acsomega.0c01519] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Guo H, Diao Q. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity. CTMC 2020;20:1481-92. [DOI: 10.2174/1568026620666200310122741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
112 Bhensdadia KA, Lalavani NH, Baluja SH. Synthesis of New Thieno[2,3-d]pyrimidines Containing a 1,2,3-Triazole Ring and Their Therapeutic Response in NCI-60 Cell Line Panel. Russ J Org Chem 2021;57:1668-77. [DOI: 10.1134/s107042802110016x] [Reference Citation Analysis]